ticlopidine has been researched along with Leukocytosis in 1 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Leukocytosis: A transient increase in the number of leukocytes in a body fluid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garcia, AE | 1 |
| Mada, SR | 1 |
| Rico, MC | 1 |
| Dela Cadena, RA | 1 |
| Kunapuli, SP | 1 |
1 other study available for ticlopidine and Leukocytosis
| Article | Year |
|---|---|
Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharide-induced arthritis.
Topics: Animals; Arthritis, Experimental; Clopidogrel; Cytokines; Disease Models, Animal; Drug Synergism; Fe | 2011 |